Instruction for use: Kamiren XLI want this, give me price
Trade name of the drug – Kamiren XL
Active substance: Doxazosinum
Dosage Form: tablets
Composition (per tablet): Sustained-release tablets, film-coated tablet.
doxazosin mesylate 4.85 mg (Equivalent to 4mg doxazosin)
Excipients: Valium - 104.01 mg; Calcium hydrogen phosphate anhydrous - 74.27 mg; lactose monohydrate - 74.27 mg; Magnesium stearate - 2.6 mg
shell film: Opadry White Y-1-7000 (Valium - 62.5%, titanium dioxide (E171) - 31.25%, macrogol 400 - 6.25%) - 13 mg
Pharmacotherapeutic group: Alpha-blockers
ATX C02CA04 Doxazosin
The nosological classification (ICD-10)
I10 Essential (primary) hypertension: hypertension; Arterial hypertension; Arterial hypertension crisis course; Essential Hypertension; Essential hypertension; Essential hypertension; Essential hypertension; Essential hypertension; Primary hypertension; Arterial hypertension, complications of diabetes; The sudden increase in blood pressure; Hypertensive disorders of blood circulation; hypertensive condition; hypertensive crises; arterial Hypertension; malignant Hypertension; Hypertonic disease; hypertensive crises; accelerated hypertension; malignant hypertension; The aggravation of hypertensive disease; Transient hypertension; Isolated systolic hypertension
I15 Secondary hypertension: Arterial hypertension, complications of diabetes; hypertension; The sudden increase in blood pressure; Hypertensive disorders of blood circulation; hypertensive condition; hypertensive crises; hypertension; arterial Hypertension; malignant Hypertension; hypertensive crises; accelerated hypertension; malignant hypertension; The aggravation of hypertensive disease; Transient hypertension; hypertension; Arterial hypertension; Arterial hypertension crisis course; renovascular hypertension; Hypertension symptomatic; Renal hypertension; Renovascular hypertension; renovascular hypertension; Symptomatic hypertension
N40 Hyperplasia of prostate gland: Prostate adenoma; BPH; Prostatauxe; prostate Hypertrophy; Dysuric disorders caused by benign prostatic hyperplasia; Dizuricheskie disorder with benign prostatic hyperplasia; Dysuria with prostate cancer; Benign prostatic giperpalaziya; Benign prostatic hyperplasia; Benign prostatic hyperplasia stages 1 and 2; Benign prostatic hyperplasia I degree; Benign prostatic hyperplasia II degree; Benign prostatic hypertrophy; The disease of the prostate gland; Acute urinary retention related to benign prostatic hyperplasia; Benign prostatic hyperplasia stages 1 and 2 in combination with prostatitis; paradoxical ischuria
Pharmacological Properties of Kamiren XL
Pharmachologic effect - Mode of action - antihypertensive.
Kamiren XL Dosage and Administration
Inside, it is not liquid, squeezed small amounts of liquid during breakfast.
If reception Kamiren® CL drug skipped further the missed dose and continue to not accept the application of the scheme established by the drug.
Arterial hypertension. The recommended initial dose - 1 tab. (4 mg) once a day one. After the first dose the patient must stay in bed for 6-8 hours. It is required in relation to those likely to develop a phenomenon that first dose, is especially pronounced on application of the foregoing background diuretics.
Maximum therapeutic effect is achieved within 4 weeks of therapy. If, after 4 weeks of treatment, the effect is insufficient and the patient tolerates the drug Kamiren® CL, the dose can be increased.
The maximum daily dose - 2 tab. (8 mg) once a day one.
Benign prostatic hyperplasia. The recommended dose - 1 tab. (4 mg) once a day one. The maximum daily dose - 2 tab. (8 mg) once a day one.
Elderly patients: Dosage adjustment is not required.
Renal impairment: Dosage adjustment is not required.
The long-acting tablets, film-coated, 4 mg. According to Table 10. in blister composite material polyamide / aluminum foil / PVC-aluminum foil coated with heat-resistant varnish (Coldforming OPA / A1 / PVC-A1) on both sides. 1, 3, 9 packaged in blister cardboard pack.
Krka, dd, Novo mesto, Smarjeske cesta 6, 8501 Novo mesto, Slovenia.
To contact us at the address Office in the Russian Federation:
123022, Moscow,st.2 -d Zvenigorod, 13, p.41.
Tel .: (495) 981-10-95; fax: (495) 981-10-91.
With packaging and / or packaging of the Russian company stated:
LLC "Krka-Rus", 143500, Russia, Moscow Region., Istra Str. Moscow, 50.
Tel .: (495) 994-70-70; fax: (495) 994-70-78.
Storage conditions of Kamiren XL
The temperature is not above 30 ° C.
Keep out of the reach of children.
Do not use beyond the expiration date printed on the package.
Conditions of supply of pharmacies